Scandinavian Health Ltd. (SHL), a designer and manufacturer of medical devices, has designed a new Precision Pen Injector (PPI) device that can deliver small but highly accurate drug doses.
The device will be used by Swedish biomedical company Q-Med AB to deliver Restylane Vital™ Light, its treatment for rejuvenating delicate skin.
According to SHL, the device replaces traditional syringes where accuracy can be difficult to control, with the new PPI enabling users to quickly and precisely deliver 200 doses with an accuracy far exceeding the requirements of pen-injector standards.
Ad Statistics
Times Displayed: 16578
Times Visited: 289 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Over the years SHL had developed a number of pipeline products ready to be customized for specific projects, and it was one of these products that provided the platform for the PPI, enabling the company to quickly develop a solution for Q-Med, according to the announcement.
"We are excited about the launch of this new device. The PPI is innovative and is an example of how teamwork can overcome design and development challenges. Our customer has worked closely with us from the very beginning, with SHL staff from Sweden and Taiwan partnering up to get this unique device to market," commented Steven R. Kaufman, marketing director at SHL.
SHL Group consists of three companies: SHL Medical, SHL Healthcare and SHL Technologies. SHL Medical develops high-end drug delivery devices, SHL Healthcare produces rehabilitation equipment for home and hospital markets, and SHL Technologies makes med-tech and other industrial products. The group has manufacturing facilities in Taiwan and China, design centers in Sweden, Taiwan and the USA, and employs over 1,500 worldwide.
